This inventor holds 3 USPTO granted patents. Top assignees: Athena Diagnostics, Inc., Biostratum, Inc., Other. Active years: 2001-2010.
Company Filing History:
1 out of 23 
1 out of 7 
1 out of 834,307 Years Active: 2001-2010
Title: Minna Mannikko: Innovator in Genetic Research
Introduction
Minna Mannikko is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of genetic research, particularly in understanding kidney diseases. With a total of 3 patents, her work has paved the way for advancements in medical diagnostics and therapeutics.
Latest Patents
Mannikko's latest patents focus on the Nephrin gene and protein. The first patent provides compositions and methods for detecting susceptibility to basement membrane disease, specifically congenital nephrotic syndromes of the Finnish type. This invention includes nucleic acids and proteins that are essential for diagnosing diseases and identifying small molecule therapeutics for treating conditions associated with proteinuria and kidney disease. The second patent reiterates similar themes, emphasizing the importance of these compositions in medical diagnostics and treatment.
Career Highlights
Throughout her career, Minna Mannikko has worked with notable companies, including Athena Diagnostics, Inc. Her expertise in genetic research has been instrumental in developing innovative solutions for complex medical issues.
Collaborations
Mannikko has collaborated with esteemed colleagues such as Ulla Lenkkeri and Karl Kristian Tryggvason. These partnerships have further enhanced her research and contributed to the advancement of genetic studies.
Conclusion
Minna Mannikko's contributions to genetic research, particularly in relation to kidney diseases, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to improving medical diagnostics and therapeutics.